Target intelligence / Profile preview

Systemic nutritional repletion

Molecular classification
Other
01

Overview

Systemic nutritional repletion is a clinical intervention and therapeutic process rather than a specific molecular target such as a receptor or enzyme. It involves the administration of essential nutrients via enteral or parenteral routes to individuals who are unable to maintain adequate nutritional status through oral intake (NIH, 2023). This process is vital for managing patients with severe malnutrition, cachexia, or malabsorption syndromes, and it plays a critical role in supporting metabolic demands during critical illness or recovery from major surgery (ASPEN, 2021). The primary biological objective is to restore metabolic homeostasis, facilitate tissue repair, and support immune function. However, the intervention requires careful monitoring to prevent refeeding syndrome, a potentially fatal condition caused by rapid shifts in electrolytes and fluids when nutrition is reintroduced to severely malnourished patients (StatPearls, 2023). Because it describes a broad medical strategy involving various nutrient components and delivery methods, it is not classified as a discrete pharmacological target.

Other names
Nutritional supportNutritional rehabilitationTotal parenteral nutrition (TPN)Enteral nutritionRefeeding
02

Mechanism of action

The provision of exogenous macronutrients (carbohydrates, proteins, and fats) and micronutrients (vitamins and minerals) to restore cellular function, reverse catabolic states, and replenish depleted body stores (StatPearls, 2023).

03

Biological functions

Metabolic homeostasisEnergy balanceTissue repairImmune responseAnabolism
04

Disease associations

MalnutritionCachexiaAnorexia nervosaMalabsorption syndromeCritical illnessSarcopenia
05

Safety considerations

Refeeding syndrome (characterized by hypophosphatemia, hypokalemia, and hypomagnesemia)HyperglycemiaParenteral nutrition-associated liver disease (PNALD)Catheter-related bloodstream infections (CRBSI)Fluid overload and pulmonary edema
06

Interacting drugs

Amino acid solutions (e.g., Aminosyn)

4 more in the full profile.

07

Biomarkers

Serum albuminPrealbumin (Transthyretin)TransferrinNitrogen balanceBody Mass Index (BMI)Serum electrolytes (Phosphorus, Potassium, Magnesium)

Beyond the preview

Go deeper on Systemic nutritional repletion.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Systemic nutritional repletion.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call